CRESCENT BIOPHARMA, INC.
CBIO
12 insider filings · Latest: Jun 22, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | Jun 23 8:04 PM | Ryan LynchTreasurer, Senior Vice President of Finance and Chief Accounting Officer. | Sale | 465 | $17.99 | $8.4K | 13,871(D) | View → |
| Jun 22, 2026 | Jun 23 8:04 PM | Jan PinkasChief Scientific Officer | Sale | 1,288 | $17.99 | $23.2K | 22,239(D) | View → |
| Jun 22, 2026 | Jun 23 8:03 PM | Richard William ScalzoChief Financial Officer | Sale | 1,112 | $17.99 | $20.0K | 20,298(D) | View → |
| Jun 22, 2026 | Jun 23 8:03 PM | Barbara Harlin BisphamGeneral Counsel and Corporate Secretary. | Sale | 1,218 | $17.99 | $21.9K | 19,330(D) | View → |
| Jun 22, 2026 | Jun 23 8:02 PM | Ellie Eunkyung ImChief Medical Officer | Sale | 1,219 | $17.99 | $21.9K | 22,069(D) | View → |
| Jun 22, 2026 | Jun 23 8:02 PM | Jonathan McneillPresident and COO | Sale | 20,549 | $17.99 | $369.7K | 139,158(D) | View → |
| Jun 22, 2026 | Jun 23 8:01 PM | Joshua T BrummDirector, Chief Executive Officer | Sale | 42,305 | $17.99 | $761.1K | 281,212(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | Jun 3 11:48 PM | Jonathan ViolinDirector | Grant/Award | 11,050 | $17.01 | 11,050(D) | View → |
| Jun 2, 2026 | Jun 3 11:48 PM | David Charles LubnerDirector | Grant/Award | 11,050 | $17.01 | 11,050(D) | View → |
| Jun 2, 2026 | Jun 3 11:47 PM | Alexandra BalcomDirector | Grant/Award | 11,050 | $17.01 | 11,050(D) | View → |
| Jun 2, 2026 | Jun 3 11:47 PM | Susan MoranDirector | Grant/Award | 11,050 | $17.01 | 11,050(D) | View → |
| Jun 2, 2026 | Jun 3 11:46 PM | Fairmount Funds Management LLCDirector, 10% Owner | Grant/Award | 11,050 | $17.01 | 11,050(I) | View → |